WuXi AppTec Co 603259.SS · CNY
Health Care · Life Sciences Tools & Services · Shanghai · 🇨🇳 China
150.29
+2.24%
Close of 9 Nov 2026, in CNY
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About WuXi AppTec Co
Its shares trade on Shanghai under the ticker 603259.SS. It has been listed since 8 May 2018. In the fiscal year to 31 December 2025, it reported revenue of CN¥45.46bn and net income of CN¥19.15bn. At that date it held total assets of CN¥103.12bn and shareholders' equity of CN¥79.71bn.
WuXi AppTec Co Ltd is a CN-based company operating in Life Sciences Tools & Services industry. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2018-05-08. WuXi AppTec Co., Ltd. is a China-based investment holding company principally engaged in the provision of new drug research and development (R&D), production and supporting services, as well as related technology platform services. The firm is mainly engaged in the discovery, development and production of small molecule drugs, cell therapies and gene therapies, as well as providing testing services for medical devices. The firm mainly conducts its businesses through four segments, including China-based Laboratory Services segment, Contract Manufacturing organization/contract development and manufacturing organization services (CMO/CDMO services) segment, US-based Laboratory Services segment and Clinical Research segment.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Life Sciences Tools & Services
- Listed since
- 8 May 2018
- Employees
- 21,744
- Website
- wuxiapptec.com.cn ↗
Leadership
Pay as last reported
- Dr. Ge LiChairman of the Board, President, Chief Executive Officer, Executive Director, since 2017CN¥42.0m
- Dr. Minzhang ChenCo-Chief Executive Officer, Executive Director, since 2020CN¥10.9m
- Dr. Qing YangCo-Chief Executive Officer, Executive Director, since 2017CN¥7.6m
- Mr. Edward HuVice Chairman of the Board, Global Chief Investment Officer, Executive Director, since 2017CN¥8.4m
- Ms. Ming ShiChief Financial OfficerCN¥5.1m
- Mr. Zhaohui ZhangVice President, Executive Director, Chief Operating Officer of China Region, since 2017CN¥7.0m
- Mr. Yuanzhou ZhangSecretary of the Board, Joint Company SecretaryCN¥1.2m
- Mr. Xiaomeng TongNon-Executive Director, since 2017
- Mr. Yibing WuNon-Executive Director, since 2017
- Mr. Xuesong LengIndependent Director
- Ms. Shaohua LuIndependent DirectorCN¥233,300
- Dr. Wei YuIndependent DirectorCN¥233,300
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 89
- Environment
- 99
- Social
- 99
- Governance
- 70
- Direct emissions (scope 1)
- 66,471.64 t
- Energy emissions (scope 2)
- 531,112.11 t
- Value chain emissions (scope 3)
- 1,689,819.84 t
- Women in the workforce
- 54.71%
- Carbon reduction policy
- Yes
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- WuXi AppTec Co Ltd possesses several notable strengths that contribute to its success in the market. Firstly, the company has a strong presence in the global pharmaceutical and biotechnology industry, allowing it to leverage its vast network and expand its customer base. Additionally, WuXi AppTec has a reputation for providing high-quality contract research and manufacturing services, which has earned the trust of numerous clients.
Weaknesses
- Despite its strengths, WuXi AppTec Co Ltd also faces a number of weaknesses that need to be addressed. One major weakness is its heavy reliance on key customers, which poses a potential risk if these clients were to significantly reduce or halt their business with the company. Furthermore, WuXi AppTec operates in a highly competitive and rapidly evolving industry, requiring constant innovation and adaptability to stay ahead.
Opportunities
- There are several opportunities that WuXi AppTec Co Ltd can capitalize on to fuel its growth. Firstly, the increasing demand for outsourced R&D and manufacturing services presents a significant opportunity for the company to expand its market share. Additionally, the growing focus on personalized medicine and the development of targeted therapies create new avenues for WuXi AppTec to provide specialized services to pharmaceutical and biotech companies.
Threats
- WuXi AppTec Co Ltd faces various threats that could potentially impact its operations and profitability. One significant threat is the emergence of regulatory changes and stricter compliance requirements, which could increase the company's costs and hinder its ability to deliver services efficiently. Moreover, the constant risk of intellectual property theft and competition from both domestic and international players poses a challenge to maintaining market dominance.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.